APA (7th ed.) Citation

Strøbæk, D., Brown, D., Jenkins, D., Chen, Y. ‐. J., Coleman, N., Ando, Y., . . . Christophersen, P. (2013). NS6180, a new KCa3.1 channel inhibitor prevents T-cell activation and inflammation in a rat model of inflammatory bowel disease. British Journal of Pharmacology, 168(2), 432. https://doi.org/10.1111/j.1476-5381.2012.02143.x

Chicago Style (17th ed.) Citation

Strøbæk, D., et al. "NS6180, a New KCa3.1 Channel Inhibitor Prevents T-cell Activation and Inflammation in a Rat Model of Inflammatory Bowel Disease." British Journal of Pharmacology 168, no. 2 (2013): 432. https://doi.org/10.1111/j.1476-5381.2012.02143.x.

MLA (9th ed.) Citation

Strøbæk, D., et al. "NS6180, a New KCa3.1 Channel Inhibitor Prevents T-cell Activation and Inflammation in a Rat Model of Inflammatory Bowel Disease." British Journal of Pharmacology, vol. 168, no. 2, 2013, p. 432, https://doi.org/10.1111/j.1476-5381.2012.02143.x.